Vanguard Group Inc
- SEC CIK
- 0000102909
- Latest filing
- Jan 29, 2026
ABVC holding history
Abvc Biopharma, Inc. in every 13F filed by Vanguard Group Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ABVC overviewAll 13F holders of ABVCFull Q4 2025 holdings
- Shares (Q4 2025)
- 287,937
- Value
- $613.3K
- % of portfolio
- <0.1%
- Quarters held
- 18
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2025 | 287,937 | $613.3K | <0.1% | +20,487+7.7% | Added | Holders |
| Q3 2025 | 267,450 | $813.0K | <0.1% | +155,917+139.8% | Added | Holders |
| Q2 2025 | 111,533 | $248.2K | <0.1% | +64,586+137.6% | Added | Holders |
| Q1 2025 | 46,947 | $49.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 46,947 | $27.7K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 46,947 | $32.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 46,947 | $36.3K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 46,947 | $61.5K | <0.1% | +19,700+72.3% | Added | Holders |
| Q4 2023 | 27,247 | $31.6K | <0.1% | +8,926+48.7% | Added | Holders |
| Q3 2023 | 18,321 | $19.1K | <0.1% | −369,192−95.3% | Reduced | Holders |
| Q2 2023 | 387,513 | $201.3K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 387,513 | $248.0K | <0.1% | +12,000+3.2% | Added | Holders |
| Q4 2022 | 375,513 | $234.7K | <0.1% | +371+0.1% | Added | Holders |
| Q3 2022 | 375,142 | $330.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 375,142 | $398.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 375,142 | $1.02M | <0.1% | +2,382+0.6% | Added | Holders |
| Q4 2021 | 372,760 | $1.26M | <0.1% | +332,200+819.0% | Added | Holders |
| Q3 2021 | 40,560 | $94.0K | <0.1% | +40,560 | New | Holders |